A neuro-cognitive gym programmed to enhance human performance and brain-body health
Post-money valuation โ
$49.2M
As of Jun 2022 ยท from SMARTfit Common Stock 1 ยท pre-money + amount raised, not a traded price
Total raised
$130,610
Across 1 round since 2022
Latest share price
$1.12
SMARTfit Common Stock 1 offering price
Financials
FY2019โFY2024 ยท from SEC filings ยท hover any figure for its source
$902K
โ$2.9M
2019
$697K
โ$2.4M
2020
$921K
โ$2.6M
2021
$939K
$4.8M
2022
$584K
$1.7M
2023
$657K
$1.6M
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$901,555
$697,363
$921,382
$938,549
$583,849
$657,438
Cost of goods sold
$517,336
$224,146
$274,825
$298,343
$187,683
$197,143
Gross margin
43%
68%
70%
68%
68%
70%
Net income
-$2,937,322
-$2,449,769
-$2,634,579
$4,783,764
$1,708,943
$1,615,818
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$11,290
$8,271
$22,617
$462,179
$128,863
$52,146
Accounts receivable
$3,768
$74,588
$9,373
$55,968
$11,851
$61,280
Total assets
$5,485,525
$4,213,131
$2,862,770
$691,480
$1,137,507
$891,419
Short-term debt
$1,872,590
$884,355
$1,591,557
$2,202,904
$1,755,401
$3,142,301
Long-term debt
$236,890
$10,739,680
$12,492,147
$831,711
$4,644,190
$5,748,267
Total liabilities
$2,109,480
$11,624,035
$14,083,704
$3,034,615
$6,399,591
$8,890,568
Other
Headcount
โ
13
13
13
8
10
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.